johnson & johnson to buy medtech company abiomed for $380 per share in cash
Published 2 years ago • 2.1K plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
4:01
jim cramer explains why he loves johnson & johnson's move to buy abiomed
-
2:04
j&j to buy heart pump maker abiomed in $16.6 billion deal
-
0:28
johnson & johnson to buy danvers-based abiomed for $16.6 billion
-
1:37
johnson & johnson to buy momenta for about $6.5 billion
-
8:36
full interview: abiomed ceo mike minogue joins mad money with jim cramer
-
2:33
introducing johnson & johnson medtech
-
11:23
why the biggest pharma company in the u.s. is breaking up
-
12:00
johnson & johnson - bigger than you know
-
5:15
tell me about yourself | best answer (from former ceo)
-
2:14
j&j in healthcare
-
0:36
the next era of medtech is here.
-
4:10
why this healthcare equity expert says johnson & johnson is a buying opportunity
-
1:50
johnson & johnson ceo touts 'smart' data approach to new medicines at new research center
-
2:57
horizon therapeutics in preliminary sale talks with amgen, sanofi, j&j
-
4:53
johnson & johnson shares rising as earnings report shows revenue beat
-
2:15
working at abiomed: andrew greenfield, vp of marketing and general manager
-
1:52
johnson & johnson global services: why j&j?
-
0:54
joe beggs, ceo & co-founder of hive medical discusses the benefits of the medtech innovator program
-
2:25
jim cramer gives johnson & johnson his stamp of approval
-
0:19
president joe biden to visit emergent biosolutions' baltimore lab making johnson & johnson's covid-1
-
5:02
j&j ceo breaks down the plan to split into two public companies